Encycle Therapeutics

A proprietary chemistry platform from the laboratory of Dr. Andrei Yudin at the University of Toronto allows efficient synthesis of uniquely substituted ring systems comprising six to twenty or more contiguous atoms. Our core Discovery capability focuses on the design of molecules that address emerging principles in the chemical space required to mediate protein-protein interactions. The company's collaborative programs reflect the evolving understanding in this space and in the identification of key drug targets.
Company Growth (employees)
Type
Private
HQ
Toronto, CA
Founded
2012
Size (employees)
10 (est)-9%
Encycle Therapeutics was founded in 2012 and is headquartered in Toronto, CA

Encycle Therapeutics Office Locations

Encycle Therapeutics has office in Toronto
Toronto, CA

Encycle Therapeutics Metrics

Encycle Therapeutics Summary

Founding Date

2012

Total Funding

$4.6 m

Latest funding size

$2.1 m

Time since last funding

over 1 year

Investors

We estimate that Encycle Therapeutics's latest funding round in September 2015 was $2.1 m. In total, Encycle Therapeutics has raised $4.6 m
We estimate that Encycle Therapeutics's current employees are approximately 17% female and 83% male.

Encycle Therapeutics Company Life

You may also be interested in